Endocrinol Metab.  2024 Feb;39(1):186-187. 10.3803/EnM.2024.1928.

Subacute Thyroiditis in the Time of COVID-19

• Ahn HY

• KMID: 2552809
• DOI: http://doi.org/10.3803/EnM.2024.1928

Reference

1. World Health Organization. WHO COVID-19 dashboard [Internet]. Geneva: WHO;2023. [cited 2024 January 15]. Available from: https://data.who.int/dashboards/covid19/cases?n=c.

2. Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu ST, et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2021; 44:1085–90.

3. Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2021; 22:803–15.

4. Jafarzadeh A, Nemati M, Jafarzadeh S, Nozari P, Mortazavi SM. Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence. J Endocrinol Invest. 2022; 45:1835–63.

5. Christensen J, O’Callaghan K, Sinclair H, Hawke K, Love A, Hajkowicz K, et al. Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review. Intern Med J. 2022; 52:522–9.

6. Meftah E, Rahmati R, Zari Meidani F, Khodadadi S, Chitzan- Zadeh K, Esfahanian F, et al. Subacute thyroiditis following COVID-19: a systematic review. Front Endocrinol (Lausanne). 2023; 14:1126637.

7. Popescu M, Ghemigian A, Vasile CM, Costache A, Carsote M, Ghenea AE. The new entity of subacute thyroiditis amid the COVID-19 pandemic: from infection to vaccine. Diagnostics (Basel). 2022; 12:960.

8. Ganie MA, Rashid H, Qadir A, Bajaj S, Joshi SR, Kalra P, et al. Subacute thyroiditis after COVID-19 vaccination: a systematic review of the literature. Thyroid Res Pract. 2022; 19:24–41.

9. Lee J, Seo GH, Song K. Beyond acute COVID-19: investigating the incidence of subacute thyroiditis in long COVID-19 in Korea. Endocrinol Metab (Seoul). 2023; 38:455–61.